Literature DB >> 32936308

Standard Diffusion-weighted MRI for the Diagnosis of Central Retinal Artery Occlusion : A Case-Control Study.

L A Danyel1, G Bohner2, F Connolly3, E Siebert2.   

Abstract

PURPOSE: To evaluate diffusion abnormalities of the retina and optic nerve in patients with central retinal artery occlusion (CRAO) using standard stroke diffusion-weighted magnetic resonance imaging (DWI).
METHODS: In this case-control study, DWI scans of patients with nonarteritic CRAO were retrospectively assessed for acute ischemia of the retina and optic nerve. Two neuroradiologists, blinded for patient diagnosis, randomly evaluated DWI of CRAO patients and controls (a collective of stroke and transient ischemic attack [TIA] patients) for restrictions of the retina and optic nerve. We calculated statistical quality criteria and analyzed inter-rater reliability using unweighted Kappa statistics.
RESULTS: 20 CRAO patients (60,6 ± 17 years) and 20 controls (60,7 ± 17 years) were included in the study. Sensitivity, specificity, positive and negative predictive values for retinal DWI restrictions were 75%/80%/79%/76% (reader 1) and 75%/100%/100%/80% (reader 2), respectively. Unweighted Kappa was κ = 0,70 (95% CI 0,48‑0,92), indicating "substantial" interrater reliability. In comparison, sensitivity, specificity, PPV and NPV (positive and negative predictive values) for restrictions of the optic nerve in CRAO were 55%/70%/65%/61% (reader 1) and 25%/100%/100%/57% (reader 2). Inter-rater reliability was "fair" with unweighted Kappa κ = 0,32 (95% CI 0,09‑0,56).
CONCLUSIONS: Retinal diffusion restrictions were present in a majority of CRAO patients and detectable with reasonable sensitivity, high specificity and substantial inter-rater reliability. Further studies are necessary to study time dependency of retinal diffusion restrictions, improve image quality and investigate the reliability of retinal DWI to discern CRAO from other causes of acute loss of vision.

Entities:  

Keywords:  Blindness; Cerebrovascular disease; Embolism; Ischemia; Magnetic resonance imaging; Retinopathy; Stroke

Year:  2020        PMID: 32936308     DOI: 10.1007/s00062-020-00955-6

Source DB:  PubMed          Journal:  Clin Neuroradiol        ISSN: 1869-1439            Impact factor:   3.649


  6 in total

1.  Detectability of Retinal Diffusion Restriction in Central Retinal Artery Occlusion is Linked to Inner Retinal Layer Thickness.

Authors:  E Siebert; M Rossel-Zemkouo; K Villringer; K Neumann; G Bohner; L A Danyel
Journal:  Clin Neuroradiol       Date:  2022-05-03       Impact factor: 3.649

2.  Retinal and optic nerve magnetic resonance diffusion-weighted imaging in acute non-arteritic central retinal artery occlusion.

Authors:  Matthew Boyko; Oana Dumitrascu; Amit M Saindane; Joseph M Hoxworth; Ranliang Hu; Tanya Rath; Wesley Chan; Alexis M Flowers; Ehab Harahsheh; Parth Parikh; Omer Elshaigi; Benjamin I Meyer; Nancy J Newman; Valérie Biousse
Journal:  J Stroke Cerebrovasc Dis       Date:  2022-07-15       Impact factor: 2.677

3.  Retinal diffusion restrictions in acute branch retinal arteriolar occlusion.

Authors:  Leon Alexander Danyel; M Miszczuk; K Villringer; G Bohner; E Siebert
Journal:  Sci Rep       Date:  2021-10-15       Impact factor: 4.379

4.  Inner Retinal Layer Hyperreflectivity Is an Early Biomarker for Acute Central Retinal Artery Occlusion.

Authors:  Daniel A Wenzel; Sven Poli; Maria Casagrande; Vasyl Druchkiv; Martin S Spitzer; Karl Ulrich Bartz-Schmidt; Carsten Grohmann; Maximilian Schultheiss
Journal:  Front Med (Lausanne)       Date:  2022-07-06

5.  Utility of standard diffusion-weighted magnetic resonance imaging for the identification of ischemic optic neuropathy in giant cell arteritis.

Authors:  L A Danyel; M Miszczuk; C Pietrock; B T Büge; K Villringer; G Bohner; E Siebert
Journal:  Sci Rep       Date:  2022-10-03       Impact factor: 4.996

6.  Time Course and Clinical Correlates of Retinal Diffusion Restrictions in Acute Central Retinal Artery Occlusion.

Authors:  L A Danyel; M Miszczuk; F Connolly; K Villringer; G Bohner; M Rossel-Zemkouo; E Siebert
Journal:  AJNR Am J Neuroradiol       Date:  2021-07-15       Impact factor: 4.966

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.